Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists find key to gene that promotes cancer metastasis

13.04.2010
4-protein complex provides new target for thwarting cancer migration, invasion

The molecular machinery that switches on a gene known to cause breast cancer to spread and invade other organs has been identified by an international team led by scientists at The University of Texas M. D. Anderson Cancer Center. The paper was published Sunday in Nature Cell Biology's advanced online publication.

The discovery provides a target-rich environment for development of drugs to thwart expression of the RhoA gene, according to Hui-Kuan Lin, Ph.D., the paper's senior author and an assistant professor in M. D. Anderson's Department of Molecular and Cellular Oncology. RhoA overexpression has been implicated in cancer metastasis.

"There are four components to this complex, which starts RhoA expression by transcribing the gene, and we found that all of them are important to metastasis," Lin said. "Knock down any one of the four, and you can stop breast cancer metastasis by preventing RhoA expression."

Researchers built their case with a series of laboratory experiments on cell lines, followed by confirmation in a mouse model of breast cancer metastasis and then analysis of 64 prostate cancer tumors that showed overexpression of RhoA or three of its transcription complex components were strongly correlated with metastatic disease.

Transcription is the first step on a gene's path to expressing its protein. Transcription factors bind to the promoter region of the gene, causing a copy of RNA to be made from the DNA of the gene. The RNA is then translated into the corresponding protein.

The team first established the Myc protein as a transcription factor that binds to RhoA's promoter region. Knocking down Myc in cancer cell lines decreased RhoA expression, cell migration and invasion, while Myc overexpression increased all three.

Next, they found that the Skp2 overexpression also results in more RhoA, and that both Skp2 and Myc were required for the metastasis-producing RhoA to be overexpressed.

This cancer-promoting pathway is the second way Skp2 fuels cancer growth, Lin said. Skp2 has been shown to work through a separate E3 ligase pathway to destroy tumor-suppressing proteins, causing heightened cellular proliferation and the transition from normal cell to tumor.

"Skp2's E3 ligase activity is required for tumorigenesis, but not involved at all in metastasis," Lin said. Lin and colleagues also previously found that Skp2 blocks cellular senescence – a halt in cell division – in cancer cells.

The research team then found that Skp2 recruits two other proteins, p300 and Miz1, to join Myc and form the complex that transcribes RhoA.

Experiments in a mouse model of breast cancer metastasis to the lung showed that deficiency of either Myc, Skp2 or Miz1 restricted metastasis, while overexpression of each of the three proteins increased cell migration and invasion. Skp2 knockdown, for example, resulted in no metastatic nodules in the lung, compared with an average of 40 nodules when Skp2 was expressed.

Directly knocking down RhoA expression produced the same effect as blocking the Myc-Skp2-Miz1 complex. Knocking down expression of p300 resulted in decreased expression of RhoA.

In the analysis of prostate cancer tumors, expression of RhoA, Myc, Skp2 and Miz1 were significantly correlated with metastasis. Expression of the RhoA and the Myc-Skp2-Miz1 complex also were highly correlated.

Lin and colleagues note that Miz1 is thought to be a tumor-suppressor that contends with the oncogene Myc to regulate genes. In this case, the tumor-suppressor cooperates with the oncogene to launch RhoA and promote metastasis.

"Right now, there are no small-molecule agents to inhibit any of these targets," Lin said. "One future direction of research will be to find ways to target the entire transcription complex or its individual components."

Funding for this research comes from M. D. Anderson's Research Trust Scholar funds, The National Cancer Institute's Prostate Cancer Specialized Program in Research Excellence at M. D. Anderson and a Department of Defense New Investigator Award to Lin.

In addition to Lin, other co-authors from M. D. Anderson's Department of Molecular and Cellular Oncology include: first author Chia-Hsin Chan, M.D.; Szu-Wei Lee, also also a graduate student in The University of Texas Graduate School of Biomedical Sciences at Houston; Jing Wang, Ph.D.; Wei-Lei Yang, M.D., Ching-Yuan Wu, M.D., also with Chang Gung Memorial Hospital-Kaohsiung Medical Center and Chang Gung University College of Medicine, Taiwan, Juan Wu, also with State Key Laboratory of Oncology in South China and Sun Yat-Sen University Cancer Center; and Mien-Chie Hung, Ph.D., department chair, also on the faculty of The University of Texas Graduate School of Biomedical Sciences at Houston, and Center for Molecular Medicine and Graduate Institute of Cancer Biology at China Medical University and Hospital, Taiwan. Other authors include: Chien-Feng Li, M.D., Department of Pathology at Chi-Mei Medical Center; Keiichi I. Nakayama, M.D., Ph.D., Medical Institute of Bioregulation at Kyushu University at Fukuoka, Japan; Hong-Yo Kang, Ph.D., and Hsuan-Ying Huang, M.D, Graduate Institute of Clinical Medical Sciences at Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine; Pier Paolo Pandolfi, M.D., Ph.D., Cancer Genetics Program at Beth Israel Deaconess Cancer Center and Department of Medicine and Pathology at Beth Israel Deaconess Medical Center at Harvard Medical School.

About M. D. Anderson

The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For six of the past eight years, including 2009, M. D. Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report

Scott Merville | EurekAlert!
Further information:
http://www.mdanderson.org

More articles from Life Sciences:

nachricht Study suggests oysters offer hot spot for reducing nutrient pollution
17.10.2017 | Virginia Institute of Marine Science

nachricht World first for reading digitally encoded synthetic molecules
17.10.2017 | CNRS

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

Im Focus: New nanomaterial can extract hydrogen fuel from seawater

Hybrid material converts more sunlight and can weather seawater's harsh conditions

It's possible to produce hydrogen to power fuel cells by extracting the gas from seawater, but the electricity required to do it makes the process costly. UCF...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Study suggests oysters offer hot spot for reducing nutrient pollution

17.10.2017 | Life Sciences

Breaking: the first light from two neutron stars merging

17.10.2017 | Physics and Astronomy

World first for reading digitally encoded synthetic molecules

17.10.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>